Health / Medical Topics

    ATR Kinase Inhibitor AZD6738

    An orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, ATR kinase inhibitor AZD6738 selectively inhibits ATR activity by blocking the downstream phosphorylation of the serine/threonine protein kinase CHK1. This prevents ATR-mediated signaling, and results in the inhibition of DNA damage checkpoint activation, disruption of DNA damage repair, and the induction of tumor cell apoptosis. In addition, AZD6738 sensitizes tumor cells to chemo- and radiotherapy. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and survival; it is activated by DNA damage caused during DNA replication-associated stress. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    This gene is involved in cell cycle checkpoints and DNA recombination.
    ATPase, Aminophospholipid Transporter-Like, Class I, Type 8A, Member 2, encoded by the ATP8A2 gene, is an integral membrane protein has similarity to…
    ATPase WRNIP1 (665 aa, ~72 kDa) is encoded by the human WRNIP1 gene. This protein is involved in both ATP hydrolysis and…
    A class of genes that encode ATP hydrolyzing enzymes, which cycle between the ADP-bound inactive state and the ATP-bound active state. This…
    A protein domain that binds ATP and catalyzes its convertion to ADP and inorganic phosphate.
    ATPases are a group of enzymes that catalyze ATP hydrolysis coupled with another function such as transporting Ca(2+) across a membrane. These…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact